FDA Noticed Labeling Problems With Roxane Drugs Six Months Before Morphine Alert
This article was originally published in The Pink Sheet Daily
Executive Summary
Roxane's high-potency morphine packaging is being redesigned with bold colors to distinguish it from other products after overdoses including deaths.